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Locating production and income within MNEs:   






Economic accountants, who are responsible for measuring gross domestic product 
(GDP), and tax authorities, which are responsible for collecting tax revenues, face 
similar challenges with respect to multinational enterprises (MNEs): economic 
accountants want to know where within an MNE production is taking place and, thus, 
where to attribute GDP; tax authorities want to know where income from production 
is earned. Current global guidance on economic accounting and international taxation 
generally require transactions within MNEs to be recognized at market (or “arm’s 
length”) values as if the transactions are taking place among unrelated entities. 
However, the values of transactions within MNEs may not reflect economic reality 
because related entities may exchange unique products with no active markets, and 
because MNEs may be structured with one or more entities that exist for purposes 
other than production. As a result, transactions within MNEs may distort economic 
accounting statistics and tax revenues. 
 
Given the complexity and subjectivity associated with applying the arm’s length 
standard, recent and past discussions on international taxation suggest formulary 
apportionment as an alternative solution for attributing income for tax purposes within 
MNEs. Under formulary apportionment, income earned by an MNE is attributed to 
tax jurisdictions based on prescribed apportionment factors, such as sales, 
employment and tangible property, which arguably reflect an MNE’s presence in each 
jurisdiction.   
 
In the United States (US), formulary apportionment is commonly required by state tax 
authorities to determine the taxable income attributable to a state for a business that 
operates in multiple states. Under the European Commission’s proposed directive for 
a common consolidated corporate tax base, formulary apportionment is an option for 
determining tax liabilities by country for MNEs operating within the European Union 
(EU). Additionally, the Organisation for Economic Co-operation and Development 
(OECD) is currently working on a project at the request of the G20 finance ministers 
to address tax base erosion and profit shifting (BEPS). One recommendation under 
the BEPS action plan is documentation that includes country-by-country reporting. 
Under country-by-country reporting, MNEs are required to report, by country, 
earnings, revenues, number of employees, tangible assets, etc. to provide tax 
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authorities with indicators regarding the location of economic activity. Respondents to 
the BEPS project have expressed strong concern that country-by-country reporting is 
suggestive of formulary apportionment, but the OECD asserts that the purpose of 
country-by-country reporting is for tax authorities to target audit risk rather than to 
replace the arm’s length standard recommended in the OECD transfer-pricing 
guidelines, which explicitly reject formulary apportionment as a substitute for the 
arm’s length standard.1 
 
Opponents of formulary apportionment present evidence that suggests formulary 
apportionment may distort actual income attributable to a given country due to 
income that is unexplained by apportionment factors and may lead to an inefficient 
allocation of productive resources due to differences in tax rates across countries.
2
 As 
a result, formulary apportionment may yield political and administrative complexity 
that would require an unrealistic level of international cooperation.
3
   
 
Proponents of formulary apportionment concede the approach is challenged by 
political and administrative complexity, but point out that the arm’s length standard is 
challenged, too, as demonstrated by the BEPS project. However, proponents argue 
that formulary apportionment is more relevant in a global economy, in addition to 
creating a stable revenue source and promoting competitive tax policies.
4
 The bottom 
line for proponents is that formulary apportionment better reflects economic 
conditions in integrated markets such as the US or the EU. 
 
Formulary apportionment has also been proposed as an alternative to the current 
method of separate accounting for attributing income-based value-added measures to 
foreign affiliates of US MNEs for statistical purposes.
5
 Previous work reveals 
distortions in the value-added measures, which are supplemental and do not affect 




Using formulary apportionment to measure economic accounting statistics on MNEs 
does not face the concerns described above for international taxation because MNEs 
presumably do not make operating or investment decisions based on data collected for 
statistical purposes. However, formulary apportionment may affect statistics on 
MNEs and the related picture of global production. In fact, the distortions in the 
supplemental measures are considerably reduced under a method of formulary 
apportionment. Thus, the international tax discussions on formulary apportionment 
may lend useful insight for more accurate economic accounting statistics on MNEs 
and for trade and FDI policy informed by the statistics. 
 
                                                          
*
 Dylan G. Rassier (dylan.rassier@bea.gov) is an economist with the United States Bureau of 
Economic Analysis. The views expressed in this Perspective are solely those of the author and do not 
necessarily reflect those of the United States Department of Commerce or the Bureau of Economic 
Analysis. The author is grateful to Reuven Avi-Yonah, Sol Picciotto and Joann Weiner for their helpful 
peer reviews. The views expressed by the author of this Perspective do not necessarily reflect the 
opinions of Columbia University or its partners and supporters. Columbia FDI Perspectives 
(ISSN 2158-3579) is a peer-reviewed series. 
1
 OECD, Transfer Pricing Guidelines for Multinational Enterprises and Tax Administrations (Paris: 
OECD, 1995), paras. 3.58-3.74. 
2
 James R. Hines, “Income misattribution under formula apportionment”, European Economic Review, 
vol. 54 (2010), pp. 108-120. 
3
 OECD, op. cit., para. 3.66. 
 3 
                                                                                                                                                                      
4
 Joann Martens-Weiner, Company Tax Reform in the European Union: Guidance from the United 
States and Canada on Implementing Formulary Apportionment (New York:  Springer, 2006). 
5
 Dylan G. Rassier and Jennifer Koncz-Bruner, “A formulary approach for attributing measured 
production to foreign affiliates of U.S. parents,” in Susan Houseman and Michael Mandel, eds., 
Measuring the Effects of Globalization (Kalamazoo, MI: Upjohn Institute for Employment Research, 
forthcoming). 
6
 Robert E. Lipsey, “Measuring the location of production in a world of intangible productive assets, 
FDI, and intrafirm trade,” Review of Income and Wealth, vol. 56 (2010), pp. S99-S110. 
 
 
The material in this Perspective may be reprinted if accompanied by the following acknowledgment: 
“Dylan G. Rassier, ‘Locating production and income within MNEs: An alternative approach based on 
formulary apportionment,’ Columbia FDI Perspectives, No. 137, December, 22 2014. Reprinted with 
permission from the Columbia Center on Sustainable Investment (www.ccsi.columbia.edu).” A copy 
should kindly be sent to the Columbia Center on Sustainable Investment at ccsi@law.columbia.edu. 
 
For further information, including information regarding submission to the Perspectives, please 
contact: Columbia Center on Sustainable Investment, Adrian Torres, adrian.p.torres@gmail.com or 
adrian.torres@law.columbia.edu. 
 
The Columbia Center on Sustainable Investment (CCSI), a joint center of Columbia Law School and 
the Earth Institute at Columbia University, is a leading applied research center and forum dedicated to 
the study, practice and discussion of sustainable international investment. Our mission is to develop 
and disseminate practical approaches and solutions, as well as to analyze topical policy-oriented issues, 
in order to maximize the impact of international investment for sustainable development. The Center 
undertakes its mission through interdisciplinary research, advisory projects, multi-stakeholder dialogue, 




Most recent Columbia FDI Perspectives 
 
 No. 136, Gus Van Harten, “Canada’s non-reciprocal BIT with China: Would the US or Europe do 
the same?” December 8, 2014. 
 No. 135, Stephen M. Schwebel, “In defense of bilateral investment treaties,” November 24, 2014. 
 No. 134, Roel Nieuwenkamp and Kimmo Sinivuori, “The road to responsible investment treaties,” 
November 10, 2014. 
 No. 133, Julian Donaubauer, Birgit Meyer and Peter Nunnenkamp, “The crucial role of 
infrastructure in attracting FDI,” October 27, 2014. 
 No. 132, Ralph Alexander Lorz, “Germany, the Transatlantic Trade and Investment Partnership 
and investment-dispute settlement: Observations on a paradox by Ralph Alexander Lorz,” October 
13, 2014. 
 
All previous FDI Perspectives are available at http://ccsi.columbia.edu/publications/columbia-fdi-
perspectives/.  
